NCT00240110View on ClinicalTrials.gov

Valproate Efficacy in Cocaine-Bipolar Comorbidity

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Bipolar DisorderCocaine Dependence
Interventions
DRUG

Valproate

Valproate with dose titration to achieve blood levels within the therapeutic range

DRUG

Placebo

Control arm

DRUG

Lithium Carbonate

All participants were started and stabilized on lithium carbonate as a standard treatment for bipolar disorder

Trial Locations (2)

33136

University of Miami Miller School of Medicine, Department of Psychiatry, Miami

University of Miami Miller School of Medicine, Miami

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Miami

OTHER

NCT00240110 - Valproate Efficacy in Cocaine-Bipolar Comorbidity | Biotech Hunter | Biotech Hunter